Abstract
Upper extremity transplantation is an innovative reconstructive strategy with potential of immediate clinical application and the most near-term pay-off for select amputees, allowing reintegration into employment and society. Routine applicability and widespread impact of such strategies for the upper extremity amputees with devastating limb loss could be enabled by implementation of cellular therapies that integrate and unify the concepts of transplant tolerance induction with those of reconstructive transplantation. Such therapies offer the promise of minimizing the risks, maximizing the benefits and optimizing outcomes of these innovative procedures. Copyright Â
Original language | English |
---|---|
Pages (from-to) | 511-520, ix-x |
Journal | Hand Clinics |
Volume | 27 |
Issue number | 4 |
DOIs | |
State | Published - Nov 2011 |
Externally published | Yes |